New hope for native youth: study tests best ways to prevent suicide

NCT ID NCT03543865

Completed Disease control Sponsor: Johns Hopkins Bloomberg School of Public Health Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested different combinations of three programs—New Hope (coping skills), Elders Resilience (cultural strength), and Case Management—to see which best reduces suicidal thoughts and builds resilience in American Indian youth ages 10-29. The 304 participants were identified as at risk through a surveillance system or after a hospital visit. The goal is to find the most effective sequence of support for this community.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Behavioral interventions: New Hope (coping skills), Elders Resilience (cultural resilience), and Case Management
What this could lead to: If successful, this could identify the best sequence of therapies to reduce suicidal thoughts and build resilience in American Indian youth.
What could go wrong: This is a completed trial with 304 participants, but results may not apply to all communities. The interventions are behavioral, so effects can vary widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSIVE SYMPTOMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression Psychological Well-Being substance abuse substance-related disorder Suicide

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEPRESSIVE SYMPTOMS MENTAL HEALTH SUBSTANCE USE SUICIDE SURVEILLANCE

Contacts and locations

Locations

Johns Hopkins Center for American Indian Health

Whiteriver, Arizona, 85941, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.